| |
| |
|
| Insider
Information: |
Welch Daniel G |
| Relationship: |
Director |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
21,605 |
|
|
Indirect Shares
|
123,508 |
|
|
| Direct
Value |
$951,052 |
|
|
|
Indirect Value
|
$4,821,752 |
|
|
| Total
Shares |
145,113 |
|
|
| Total
Value |
$5,772,804 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -4.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
InterMune Inc |
ITMN |
Chairman, CEO and Pres... |
2014-09-29 |
0 |
2004-08-12 |
0 |
Premium* |
|
|
Seagen Inc |
SGEN |
|
2023-12-14 |
0 |
2023-12-14 |
0 |
Premium* |
|
|
Hyperion Therapeutics Inc |
HPTX |
Director |
2015-05-07 |
0 |
2014-05-27 |
0 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
Director |
2023-06-07 |
21,605 |
2016-06-09 |
0 |
Premium* |
|
|
Avexis, Inc. |
AVXS |
Director |
2018-05-15 |
0 |
2018-03-13 |
0 |
Premium* |
|
|
Structure Therapeutics Inc. |
GPCR |
Director |
2023-02-07 |
0 |
2023-02-07 |
123,508 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SGEN |
Seagen Inc |
|
– • – |
2023-12-14 |
4 |
D |
$229.00 |
$2,456,025 |
I/I |
(10,725) |
0 |
0 |
- |
|
| SGEN |
Seagen Inc |
|
– • – |
2023-12-14 |
4 |
D |
$229.00 |
$1,087,750 |
D/D |
(4,750) |
0 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-08-28 |
4 |
AS |
$209.08 |
$336,619 |
I/I |
(1,610) |
10,725 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-08-28 |
4 |
AS |
$209.01 |
$693,094 |
D/D |
(3,315) |
6,794 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-08-28 |
4 |
OE |
$135.63 |
$245,762 |
D/D |
1,812 |
10,109 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2023-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,860 |
21,605 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,044 |
8,297 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-05-15 |
4 |
OE |
$135.63 |
$252,814 |
D/D |
1,864 |
8,117 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-05-15 |
4 |
AS |
$200.02 |
$372,837 |
D/D |
(1,864) |
6,253 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-05-02 |
4 |
AS |
$200.07 |
$1,167,408 |
I/I |
(5,835) |
12,335 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-05-02 |
4 |
AS |
$200.05 |
$1,775,024 |
D/D |
(8,872) |
6,253 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-05-02 |
4 |
OE |
$64.38 |
$1,140,601 |
D/D |
8,521 |
10,066 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-05-01 |
4 |
AS |
$200.04 |
$1,487,463 |
D/D |
(7,435) |
6,604 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-05-01 |
4 |
AS |
$200.06 |
$978,293 |
I/I |
(4,890) |
18,170 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-05-01 |
4 |
OE |
$56.77 |
$444,529 |
D/D |
7,140 |
8,889 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-04-03 |
4 |
OE |
$38.82 |
$1,068,060 |
D/D |
17,525 |
7,011 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-04-03 |
4 |
AS |
$200.45 |
$2,162,296 |
I/I |
(10,725) |
12,335 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-04-03 |
4 |
AS |
$200.11 |
$4,087,548 |
D/D |
(20,275) |
4,149 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-03-15 |
4 |
OE |
$38.82 |
$79,076 |
D/D |
2,037 |
9,256 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-03-15 |
4 |
AS |
$200.05 |
$471,518 |
D/D |
(2,357) |
6,899 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-03-15 |
4 |
AS |
$200.05 |
$249,262 |
I/I |
(1,246) |
23,060 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-03-14 |
4 |
AS |
$200.00 |
$57,600 |
I/I |
(288) |
24,306 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-03-14 |
4 |
OE |
$38.82 |
$18,245 |
D/D |
470 |
13,447 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-03-14 |
4 |
AS |
$200.00 |
$108,800 |
D/D |
(544) |
12,977 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-03-13 |
4 |
OE |
$38.82 |
$593,370 |
D/D |
15,018 |
23,036 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
